1-4 of 4
Leah Gehrs
Close
Sort by
Journal Articles

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Daniel Cancilla, Michael P. Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Marvin J. Meyers, Peter G. Ruminski, Stephanie Christ, Ezhilarasi Chendamarai, Feng Gao, Leah Gehrs, Julie K. Ritchey, Michael Prinsen, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1379–1383.
https://doi.org/10.1182/bloodadvances.2023011653
Published: 2024
Includes: Supplemental data
Journal Articles

Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Armin Ghobadi, Nicole C. Foley, Jared Cohen, Michael P. Rettig, Amanda F. Cashen, Leah Gehrs, Stephanie Christ, Emily Street, Nicholas Wallace, Julie Ritchey, Neha Mehta-Shah, Peter Westervelt, Todd A. Fehniger, Brad Kahl, Nancy L. Bartlett, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (3): 513–522.
https://doi.org/10.1182/bloodadvances.2023011130
Published: 2024
Includes: Supplemental data
Journal Articles

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Clinical Trials & Observations
Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2387–2391.
https://doi.org/10.1182/bloodadvances.2019000664
Published: 2020
Journal Articles

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Clinical Trials & Observations
Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel-Angel Perales, Yi-Bin Chen, Gabrielle Meyers, John F. DiPersio
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1656–1669.
https://doi.org/10.1182/bloodadvances.2019001043
Published: 2020
Includes: Supplemental data